Experts reevaluate coverage policies and the financial impact of antiobesity medications based on updated clinical data and ...

Mintel, the experts in what consumers want and why, has today announced four key trends that will shape the global food and drink industry in the years ahead. In 2025 and beyond, expect to see GLP-1 ...

Streeting announced a collaboration with the world's largest pharmaceutical company, Lilly, which will include a five-year ...

Molecules that produce hydrogen sulfide and specifically target mitochondria significantly reduced weight gain in mice.

The case for Novo Nordisk. Right now Novo Nordisk has a considerable lead on Lilly in GLP-1 market share, and a couple of ...

The NHS cannot meet the “tidal wave” of demand for weight-loss jabs, medics say. A report calling for a review of existing ...

Studies show that people with obesity are more likely to find that ill health affects their productivity and attendance at work.

A weight-loss drug more effective than Ozempic and Wegovy has recently been approved. Here’s how it works and how it compares ...

ROACH: I am 5 feet, 1 inch tall, weigh 200 pounds, and have found it next to impossible to lose weight, even though I'm active. I swim, walk, or do yoga almost every day. I avoid most processed foods ...

In April, the New England Journal of Medicine launched a series of review ... like peptide-1 (GLP-1), the hormone that ...

A woman who takes weight loss medication has called Health Secretary Wes Streeting “naive” after he suggested weight-loss jabs could be given to unemployed people to help them return to the workplace.